T-cell-based immunosuppressive therapy inhibits the development of natural antibodies in infant baboons

Transplantation

Volumn 93, Issue 8, 2012, Pages 769-776

  Dons, Eefje M ^a,b   Montoya, Claudia ^a   Long, Cassandra E ^a   Hara, Hidetaka ^a   Echeverri, Gabriel J ^a   Ekser, Burcin ^a   Ezzelarab, Corin ^a   Medellin, Dasha Roa ^a   Van Der Windt, Dirk J ^a,b   Murase, Noriko ^a   Rigatti, Lora H ^c   Wagner, Robert ^c   Wolf, Roman F ^d   Ezzelarab, Mohamed ^a   West, Lori J ^e   Ijzermans, Jan N M ^b   Cooper, David K C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

ABO incompatible; Antibodies; Baboon; Immunosuppressive therapy; Infant; Natural; Xenotransplantation

Indexed keywords

ABATACEPT; ANTIBODY; CD40 LIGAND MONOCLONAL ANTIBODY; GALACTOSYLGALACTOSE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTERY GRAFT; ARTICLE; BABOON; BLOOD GROUP ABO INCOMPATIBILITY; CONTROLLED STUDY; DRUG DOSE REDUCTION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES; ANTIGENS; ANTILYMPHOCYTE SERUM; AORTA, ABDOMINAL; ARTERIES; CD40 LIGAND; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; PAPIO; SWINE; T-LYMPHOCYTES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84859633793     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182481168     Document Type: Article

References (42)

1. West LJ, Pollock-Barziv SM, Dipchand AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001; 344: 793.
2. PiersonRN3rd, Dorling A, Ayares D, et al. Current status of xenotransplantation and prospects for clinical application. Xenotransplantation 2009; 16: 263.
3. Baumann BC, Stussi G, Huggel K, et al. Reactivity of human natural antibodies to endothelial cells from Galalpha(1,3)Gal-deficient pigs. Transplantation 2007; 83: 193.
4. Schaapherder AF, Daha MR, te Bulte MT, et al. Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 1994; 57: 1376.
5. Holmes BJ, Richards A, McLaughlin M, et al. Antibody responses in early graft rejection in pig-to-primate renal xenotransplantation. Transplant Proc 2001; 33: 717.
6. Oriol R, Ye Y, Koren E, et al. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433.
7. Galili U, Mandrell RE, Hamadeh RM, et al. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 1988; 56: 1730.
8. Kobayashi T, Cooper DK. Anti-Gal, alpha-Gal epitopes, and xenotransplantation. Subcell Biochem 1999; 32: 229.
9. Rood PP, Tai HC, Hara H, et al. Late onset of development of natural anti-nonGal antibodies in infant humans and baboons: Implications for xenotransplantation in infants. Transpl Int 2007; 20: 1050.
10. Ohdan H, Yang YG, Swenson KG, et al. In vivo T-cell depletion enhances production of anti-GALalpha1,3GAL natural antibodies in alpha1,3- galactosyltransferase-deficient mice. Transplantation 2000; 69: 910.
11. Cretin N, Bracy J, Hanson K, et al. The role of T cell help in the production of antibodies specific for Gal alpha 1-3Gal. J Immunol 2002; 168: 1479.
12. Stussi G, West L, Cooper DK, et al. ABO-incompatible allotransplantation as a basis for clinical xenotransplantation. Xenotransplantation 2006; 13: 390.
13. Fong SW, Qaqundah BY, Taylor WF. Developmental patterns of ABO isoagglutinins in normal children correlated with the effects of age, sex, and maternal isoagglutinins. Transfusion 1974; 14: 551.
14. Fan X, Ang A, Pollock-Barziv SM, et al. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004; 10: 1227.
15. Dipchand AI, Pollock BarZiv SM, Manlhiot C, et al. Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO-compatible. Am J Transplant 2010; 10: 389.
16. Roche SL, Burch M, O'Sullivan J, et al. Multicenter experience of ABO-incompatible pediatric cardiac transplantation. Am J Transplant 2008; 8: 208.
17. Kaplon RJ, Michler RE, Xu H, et al. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. Transplantation 1995; 59: 1.
18. Michler RE, Minanov OP, Artrip JH, et al. Immature host for xenotransplantation. World J Surg 1997; 21: 924.
19. Kawai T, Andrews D, Colvin RB, et al. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000; 6: 114. (Pubitemid 30082329)
20. Knosalla C, Gollackner B, Cooper DK. Anti-CD154 monoclonal antibody and thromboembolism revisted. Transplantation 2002; 74: 416.
21. Kirk AD, Burkly LC, Batty DS, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5: 686.
22. Kuwaki K, Tseng YL, Dor FJ, et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med 2005; 11: 29.
23. Durie FH, Foy TM, Masters SR, et al. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994; 15: 406.
24. Knosalla C, Ryan DJ, Moran K, et al. Initial experience with the human anti-human CD154 monoclonal antibody, ABI793, in pig-to-baboon xenotransplantation. Xenotransplantation 2004; 11: 353.
25. Tseng YL, Kuwaki K, Dor FJ, et al. alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 2005; 80: 1493.
26. Kover KL, Geng Z, Hess DM, et al. Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat. Diabetes 2000; 49: 1666.
27. Mihara M, Tan I, Chuzhin Y, et al. CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus. J Clin Invest 2000; 106: 91.
28. Cooper DK, Teuteberg JJ. Pig heart xenotransplantation as a bridge to allotransplantation. J Heart Lung Transplant 2010; 29: 838.
29. Loveland BE, Milland J, Kyriakou P, et al. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons. Xenotransplantation 2004; 11: 171.
30. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411.
31. Ekser B, Rigotti P, Gridelli B, et al. Xenotransplantation of solid organs in the pig-to-primate model. Transpl Immunol 2009; 21: 87.
32. Ezzelarab M, Garcia B, Azimzadeh A, et al. The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation 2009; 87: 805.
33. Lin SS, Weidner BC, Byrne GW, et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101: 1745.
34. Wolf RF, Eberle R, White GL. Generation of a specific-pathogen-free baboon colony. J Am Assoc Lab Anim Sci 2010; 49: 814.
35. Busch J, Specht S, Ezzelarab M, et al. Buccal mucosal cell immunohistochemistry: A simple method of determining the ABH phenotype of baboons, monkeys, and pigs. Xenotransplantation 2006; 13: 63.
36. Tai HC, Campanile N, Ezzelarab M, et al. Measurement of anti-CD154 monoclonal antibody in primate sera by competitive inhibition ELISA. Xenotransplantation 2006; 13: 566.
37. Ekser B, Long C, Echeverri GJ, et al. Impact of thrombocytopenia on survival of baboons with genetically modified pig liver transplants: Clinical relevance. Am J Transplant 2010; 10: 273.
38. Yeh P, Ezzelarab M, Bovin N, et al. Investigation of potential carbohydrate antigen targets for human and baboon antibodies. Xenotransplantation 2010; 17: 197.
39. Hara H, Long C, Lin YJ, et al. In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transpl Int 2008; 21: 1163.
40. Rood PP, Hara H, Busch JL, et al. Incidence and cytotoxicity of antibodies in cynomolgus monkeys directed to nonGal antigens, and their relevance for experimental models. Transpl Int 2006; 19: 158.
41. Ezzelarab M, Welchons D, Torres C, et al. Atorvastatin down-regulates the primate cellular response to porcine aortic endothelial cells in vitro. Transplantation 2008; 86: 733.
42. Morelli AE, Coates PT, Shufesky WJ, et al. Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: Implications for transplantation. Transplantation 2007; 83: 656.